Equine p-tau181 antibody and antigen (recombinant protein)

 Download 

Product information

Size： 1mg | 10mg | 100mg

Catalog No.	Description	US $ Price (per mg)	First Order Discount	First Order Discount Price
GMP-EQU-p-tau181-Ag01	Recombinant Equine p-tau181 protein	3090
GMP-EQU-p-tau181-Ab01	Anti-Equine p-tau181 mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-p-tau181-Ab02	Anti-Equine p-tau181 mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-p-tau181-Ab03	Anti-Equine p-tau181 mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-p-tau181-Ab04	Anti-Equine p-tau181 mouse monoclonal antibody (mAb)	1953	20%	1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

Product Description

Cat No. of Products	GMP-EQU-p-tau181-Ag01
Product Name	Recombinant Equine p-tau181 protein
Target/Biomarker	Equine Phospho-tau181 (p-tau181)
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Equine Phospho-tau181 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau181 level test of animal Equine/Horse with Alzheimer Disease(AD).
Tag	His
Products description	Recombinant Equine p-tau181 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-EQU-p-tau181-Ab01, GMP-EQU-p-tau181-Ab02, GMP-EQU-p-tau181-Ab03, GMP-EQU-p-tau181-Ab04
Product Name	Anti-Equine p-tau181 mouse monoclonal antibody (mAb)
Target/Biomarker	Equine Phospho-tau181 (p-tau181)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Anti-Equine Phospho-tau181 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau181 level test of animal Equine/Horse with Alzheimer Disease(AD).
Tag	mFc
Products description	Anti-Equine p-tau181 mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Associated products

Target/Biomarker information

Equine p-tau181, the phosphorylated Tau Protein 181 variant specific to horses, is a beacon within the intricate landscape of equine neurobiology. At its core, it is a Tau protein that has undergone precise phosphorylation at residue 181. Under normal circumstances, Tau proteins serve as the guardians of microtubule stability within neuronal cells, ensuring proper intracellular transport and the structural integrity of axons. However, when neurodegenerative processes take center stage, the narrative evolves. Phosphorylation events can trigger the misfolding and aggregation of Tau proteins, and equine p-tau181 is no exception. It tends to aggregate and form neurofibrillary tangles within the neural tissues of afflicted horses. These neurofibrillary tangles, reminiscent of those observed in human neurodegenerative diseases such as Alzheimer's, are a pathological hallmark of various equine neurodegenerative conditions. The accumulation of p-tau181 in neurofibrillary tangles contributes to progressive neuronal dysfunction, ultimately manifesting as clinical signs in conditions like equine neuroaxonal dystrophy (eNAD) and specific encephalopathies.

About GDU